글로벌 지혈 및 조직 밀봉제 시장 – 2028년까지의 산업 동향 및 예측

지혈제 및 조직 봉합제의 시장 분석 및 통찰력

지혈 및 조직 밀봉제 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 71억 4,255만 달러에 달할 것으로 분석하고 위에 언급된 예측 기간 동안 7.33%의 CAGR로 성장할 것이라고 예측했습니다.

지혈제와 접착제 및 실런트는 현대 수술 절차에 매우 유용한 지지체입니다. 국소 지혈제는 수술 중에 먼저 사용하고 수술 후에는 덜 사용합니다. 이러한 제품은 또한 생 표면 출혈, 흘러나오는 정맥 출혈, 뼈 출혈 및 바늘 뚫림 출혈을 분산하는 데 사용할 수 있습니다.

스포츠 활동과 교통사고로 인한 부상 발생률의 증가는 지혈 및 조직 밀봉제 시장의 성장과 수요를 강화할 것으로 예상되는 중요한 요인 중 하나입니다. 또한 만성 질환이 있는 노인 인구의 증가와 위장 , 심혈관 및 폐 수술의 증가도 2021년에서 2028년까지의 예측 기간 동안 글로벌 시장 성장에 기여할 것으로 예상됩니다. 또한 기술의 급속한 발전과 유리한 보상도 시장 성장을 촉진할 가능성이 높습니다. 나아가, 필요한 의료 시설을 저렴하고 쉽게 구할 수 있기 때문에 다른 의료 시설보다 병원을 선호하는 인구가 증가한 것도 지혈 및 조직 밀봉제 시장 성장을 촉진할 것으로 예상되는 중요한 요인 중 하나입니다.  

다양한 일반 수술과 덜 침습적인 수술에서 혈액 손실 예방을 위한 지혈제 제품의 적용이 증가하고, 다른 기존 시술보다 최소 침습 수술을 선호하는 경향이 증가함에 따라 2021년에서 2028년까지의 예측 기간 동안 지혈 및 조직 밀봉제 시장에 상당한 성장 기회가 제공될 것으로 예상됩니다.

However, the strict regulatory scenario regarding approval of these sealing agents and high cost coupled with tissue sealing agents are expected to curb the growth of the hemostasis and tissue sealing agents market, whereas the rise in the uses of off label hemostat products can challenge the growth of the hemostasis and tissue sealing agents market.

This hemostasis and tissue sealing agents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hemostasis and tissue sealing agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Hemostasis and Tissue Sealing Agents Market Scope and Market Size

Hemostasis and tissue sealing agents market is segmented on the basis of product type, material type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The product type segment of the hemostasis and tissue sealing agents market is segmented into topical hemostats and adhesive and tissue sealant. Topical hemostats have further been segmented into Active hemostas, mechanical hemostas, flowable hemostas, fibrin sealants and topical thrombin products. Adhesive and tissue sealant has further been segmented into synthetic, natural and adhesion barrier.
• On the basis of material type, the hemostasis and tissue sealing agents market is segmented into collagen based, oxidized regenerated cellulose (orc) based, gelatin based, polysaccharide based and others.
• Based on application, the hemostasis and tissue sealing agents market is segmented into general surgery, minimally invasive surgery and others.
• On the basis of end user, the hemostasis and tissue sealing agents market is segmented into hospitals, ambulatory surgical centers, home care settings and others.

Hemostasis and Tissue Sealing Agents Market Country Level Analysis

Hemostasis and tissue sealing agents market is analyzed and market size insights and trends are provided by country, product type, material type, application and end user as referenced above.

The countries covered in the hemostasis and tissue sealing agents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the hemostasis and tissue sealing agents market owing to the rise in the prevalence of cardiovascular disorders, diabetes and cancer. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the medical tourism and surgical procedures. 

The country section of the hemostasis and tissue sealing agents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Hemostasis and tissue sealing agents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hemostasis and tissue sealing agents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hemostasis and tissue sealing agents market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Hemostasis and Tissue Sealing Agents Market Share Analysis

Hemostasis and tissue sealing agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hemostasis and tissue sealing agents market.

지혈 및 조직 봉합제 시장 보고서에서 다루는 주요 업체는 Johnson & Johnson Services, Inc., CryoLife, Inc., Baxter, Ethicon US, LLC, Integra Lifesciences Corporation, BD, Pfizer Inc, Medtronic, B. Braun Melsungen AG, Sysmex, Terumo Corporation 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-63284